Leonardo DRS, Inc.
DRS
31.27
-1.50
-4.58%
Leonardo DRS, Inc.
US · DRS
#1485 by market cap
Listed 2021
31.27
-1.50
-4.58%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
Recent news
-
Rating change
CCORF Maintains Leonardo DRS, Inc.(DRS.US) With Buy Rating, Raises Target Price to $55Market Newswire · 2026/9/18
-
Rating change
BTIG Maintains Leonardo DRS, Inc.(DRS.US) With Buy Rating, Maintains Target Price $50Market Newswire · 2026/11/3
-
Rating change
CCORF Maintains Leonardo DRS, Inc.(DRS.US) With Buy Rating, Maintains Target Price $55Market Newswire · 2026/10/30
-
Press Release: Leonardo DRS Appoints Shaveta J. Kapoor as Chief Human Resources OfficerDow Jones · 2026/11/5
-
Rating change
Morgan Stanley Initiates Leonardo DRS, Inc.(DRS.US) With Hold Rating, Announces Target Price $44Market Newswire · 2026/10/16
-
Company notice
Leonardo DRS, Inc. | 4: Statement of changes in beneficial ownership of securities-Officer Dippold MichaelSEC · 2026/11/4
-
Rating change
J.P. Morgan Maintains Leonardo DRS, Inc.(DRS.US) With Hold Rating, Maintains Target Price $53Market Newswire · 2026/8/5
-
Leonardo DRS, Inc. Just Recorded A 25% EPS Beat: Here's What Analysts Are Forecasting NextSimply Wall St · 2026/11/1
-
Company notice
Leonardo DRS, Inc. | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuersSEC · 2026/11/14
-
Leonardo DRS, Inc. To Go Ex-Dividend On November 12th, 2026 With 0.09 USD Dividend Per ShareMarket Newswire · 2026/11/11
-
Rating change
Morgan Stanley Maintains Leonardo DRS, Inc.(DRS.US) With Hold Rating, Maintains Target Price $44Market Newswire · 2026/10/19
-
J.P. Morgan Maintains Leonardo DRS, Inc.(DRS.US) With Hold Rating, Cuts Target Price to $48Market Newswire · 2026/11/11
-
Company notice
Optim: Optim has completed its first M&A deal in the healthcare sector, acquiring MediTech Co., Ltd., which provides the medical imaging sharing service "Drs' HotLine," as a subsidiary.JPX · 2026/11/2
-
Company notice
Leonardo DRS, Inc. | 8-K: Leonardo DRS Announces Financial Results for Third Quarter 2026SEC · 2026/10/29
-
Rating change
Goldman Sachs Maintains Leonardo DRS, Inc.(DRS.US) With Buy Rating, Raises Target Price to $55Market Newswire · 2026/11/3
-
Rating change
Goldman Sachs Maintains Leonardo DRS, Inc.(DRS.US) With Buy Rating, Cuts Target Price to $53Market Newswire · 2026/10/12
-
Company notice
Leonardo DRS, Inc. | 144: Notice of proposed sale of securities pursuant to Rule 144SEC · 2026/11/2
-
Rating change
Morgan Stanley Maintains Leonardo DRS, Inc.(DRS.US) With Hold Rating, Maintains Target Price $45Market Newswire · 2026/11/2
-
There's A Lot To Like About Leonardo DRS' (NASDAQ:DRS) Upcoming US$0.09 DividendSimply Wall St · 2026/11/7
-
Rating change
Goldman Sachs Maintains Leonardo DRS, Inc.(DRS.US) With Buy Rating, Maintains Target Price $57Market Newswire · 2026/8/3
-
Company notice
Frazier Life Sciences Acquisition Corp. II | DRS: OthersSEC · 2026/9/12
-
Company notice
Leonardo DRS, Inc. | 4: Statement of changes in beneficial ownership of securities-Director TOWNSEND FRANCES FSEC · 2026/10/2
-
Rating change
A Quick Look at Today's Ratings for Leonardo DRS, Inc.(DRS.US), With a Forecast Between $47 to $55Market Newswire · 2026/7/31
-
Earnings Flash (DRS) Leonardo DRS, Inc. Reports Q3 Revenue $1.07B, Vs. FactSet Est of $1.03BMT Newswires · 2026/10/29
-
Rating change
Morgan Stanley Maintains Leonardo DRS, Inc.(DRS.US) With Hold Rating, Maintains Target Price $47Market Newswire · 2026/7/31
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 20:02:27 · For reference only, not investment advice and not tailored to your situation.
Leonardo DRS, Inc. discussion 0 comments